Clinical Trial Update: PD-L1 Targeting Molecular Imaging of Solid Tumors [NA]

View source ↗

Summary

Clinical trial update on a PD-L1 targeting molecular imaging agent for solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Gastrointestinal Tumors | NA | Status: RECRUITING